1-7 of 7
Authors: Natalie Prystajecky
Save search
Sort by
Journal Article

Impact of Age and Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection on Humoral Immune Responses After Three Doses of Coronavirus Disease 2019 mRNA Vaccine Open Access

PDF
Francis Mwimanzi and others
Open Forum Infectious Diseases, Volume 10, Issue 3, March 2023, ofad073, https://doi.org/10.1093/ofid/ofad073
Published: 09 February 2023
Journal Article

Clinical Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Relative to Delta in British Columbia, Canada: A Retrospective Analysis of Whole-Genome Sequenced Cases Free

PDF
Sean P Harrigan and others
Clinical Infectious Diseases, Volume 76, Issue 3, 1 February 2023, Pages e18–e25, https://doi.org/10.1093/cid/ciac705
Published: 30 August 2022
Journal Article

People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses Open Access

PDF
Hope R Lapointe and others
The Journal of Infectious Diseases, Volume 227, Issue 7, 1 April 2023, Pages 838–849, https://doi.org/10.1093/infdis/jiac229
Published: 07 June 2022
Journal Article

Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose Open Access

PDF
Francis Mwimanzi and others
The Journal of Infectious Diseases, Volume 226, Issue 6, 15 September 2022, Pages 983–994, https://doi.org/10.1093/infdis/jiac199
Published: 11 May 2022
Journal Article

Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada Open Access

PDF
Danuta M Skowronski and others
Clinical Infectious Diseases, Volume 75, Issue 11, 1 December 2022, Pages 1980–1992, https://doi.org/10.1093/cid/ciac290
Published: 19 April 2022
Journal Article

Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, Canada Open Access

PDF
Danuta M Skowronski and others
The Journal of Infectious Diseases, Volume 226, Issue 3, 1 August 2022, Pages 485–496, https://doi.org/10.1093/infdis/jiac023
Published: 27 January 2022
Journal Article

Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada Open Access

PDF
Danuta M Skowronski and others
Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1158–1165, https://doi.org/10.1093/cid/ciab616
Published: 09 July 2021